ADA Meeting Offers 5 Symposiums With Latest COVID-19 Findings

Individuals with diabetes, and other related underlying health conditions, are being hospitalized 6 times more often and are 12 times more likely to die of COVID-19 than those without diabetes.

The American Diabetes Association(ADA) will run its 81st Scientific Sessions remotely, Friday through June 29, 2021. During the virtual conference, attendees will receive access to nearly 2000 original research presentations and take part in discussions with leading diabetes experts.

This year’s event will feature 5 COVID-19 Symposia with the goal of highlighting cutting-edge science and the latest diabetes developments learned during the initial phases of the pandemic.

According to the ADA, the research that will be presented comes at a time when individuals with diabetes, and other related underlying health conditions, are being hospitalized 6 times more often than those without the condition, and are 12 times more likely to die of COVID-19 than those without diabetes. Further, diabetes is the second most reported underlying health condition among COVID-19 patients across the United States.

“This past 16 months elevated the need for diabetes awareness and care in a turbulent way, as diabetes ranks as one of the top risk factors for severe complications from COVID-19. Seeing the devastating impact of the pandemic on people with diabetes, the ADA is emboldened to work even harder to lead the fight against diabetes. Our mission is reinforced by researchers from around the globe committed to closely studying specific impacts and interventions to help people living with diabetes during this COVID-19 era,” said Dr. Robert Gabbay, MD, PhD, Chief Scientific & Medical Officer of the ADA, in a press release. “We look forward to displaying this in 5 comprehensive symposia to help share key learnings and set the groundwork for how we treat patients moving forward.”

Each session of the symposium will highlight the effect of COVID-19 on diabetes care, with topics ranging from treatment of long COVID-19, to addressing COVID-19 and health disparities, obesity, telehealth, and mental health among people with diabetes. After each symposium, there will be a live Q&A where attendees will be able to speak with lead researchers.

In addition to the COVID-19 Symposia, the ADA will highlight initial results from 2 studies that were part of $1 million investment in research projects investigating the link between COVID-19 and diabetes.

Visit the ADA’s website for more information about the 81st Scientific Sessions.

REFERENCE

American Diabetes Association presents latest COVID-19 findings with five comprehensive panel symposia at the 81st Scientific Sessions [news release]. June 24, 2021; ADA. Accessed June 24, 2021. [email]